TOP STORIES

• REGULATORY Pfizer’s Paxlovid Contraindicated with Many Medicines, Requires Careful Use
  February 14, 2022

• REGULATORY Japan Approves Pfizer’s Paxlovid, Second Oral COVID-19 Pill
  February 10, 2022

• ORGANIZATION Govt-Industry Arrangement for Drug Supply Survey Hits Rough Waters; FPMAJ Stands Pat on Continued Dialogue
  February 10, 2022

• REGULATORY Chuikyo Issues 2022 Reform Recommendation; Patch Prescription Limit Lowered to 63 Sheets
  February 10, 2022

• BUSINESS Chugai Sees Huge Potential in Its RAS Inhibitor with 15% of All Cancers Targeted: Research Chief
  February 9, 2022

• BUSINESS Insmed Plots Growth in Japan Biz with Arikayce and More Drugs to Follow
  February 8, 2022

• BUSINESS Shionogi Looks to File COVID Pill in Japan as Early as Next Week
  February 8, 2022

• REGULATORY Japan Mulls Early Conditional Approval for Shionogi’s COVID Pill
  February 8, 2022

• BUSINESS Pharma Industry Frets Cost and Deadline of MHLW-Ordered Carcinogen Risk Inspections
  February 7, 2022

• REGULATORY Lilly’s Retevmo Clears PAFSC for Thyroid Cancer; Lenvima/Keytruda to Get RCC Indication
  February 7, 2022

• BUSINESS Novartis Japan Developing Iptacopan as Priority Product, Initially Targeting 3 Indications
  February 4, 2022

• REGULATORY Pfizer’s COVID-19 Pill Up for PAFSC Review on Feb. 10
  February 4, 2022

• REGULATORY 9 Drugs/6 APIs for Fertility Treatment to Be Listed in April; Generics Listing in June at the Earliest: Chuikyo
  February 3, 2022

• BUSINESS 650 Astellas Staffers Choose Voluntary Redundancy, Sales Force Down to 1,200
  February 3, 2022

• REGULATORY DPO Opted Not to Apply 80% Pricing Rule for Vynmac for Clinical Benefits: Minutes
  February 2, 2022

• BUSINESS Sumitomo Dainippon Expects to Get Back on Growth Track in FY2025 after Latuda’s LOE: President
  February 2, 2022

• REGULATORY Japan Finalizes Deal for Pfizer’s COVID-19 Pills, Eyes Approval by Mid-February
  February 1, 2022

• REGULATORY Japan Won’t Give 3rd-Shot Approval for Shionogi’s Jab with Booster Trial Alone
  February 1, 2022

• ORGANIZATION Japan Market Should Grow in Single-Digit Range, Not Zero Growth: PhRMA Chair
  January 31, 2022

• REGULATORY MHLW Sets Volume Thresholds for Drug Orders to Resolve Generic Shortages
  January 28, 2022

ページ

• « 先頭
• ‹ Prev
• …
• 73
• 74
• 75
• 76
• 77
• 78
• 79
• 80
• 81
• …
• Next ›
• 最終 »